LTI-291 is primarily used in research settings for its potential neuroprotective properties. It has been investigated for its ability to modulate specific kinase pathways involved in neuronal survival and inflammation, making it a candidate for studying neurodegenerative diseases such as Parkinson’s and Alzheimer’s. Its application extends to preclinical models where it helps assess cellular responses to oxidative stress and mitochondrial dysfunction. Due to its selective activity, LTI-291 is also employed as a pharmacological tool to dissect signaling mechanisms in neural cell cultures and animal models.